The largest database of trusted experimental protocols

47 protocols using anti cd31

1

Isolation and Characterization of PDLSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fourth-generation PDLSCs were collected and washed twice with PBS containing 1% FBS. After incubation in the dark with anti-CD45, anti-CD31, anti-CD29, anti-CD90 and anti-CD105 antibodies (Invitrogen, California, USA) at 4 °C for 30 minutes. The cells were centrifuged and washed three times, and the suspension was analyzed by sorted flow cytometry (Influx, BD, New Jersey, USA). The detection of DPSC surface antibodies was the same as above, and the markers included anti-CD73, anti-CD90, anti-CD45, anti-CD31 and Nestin (Invitrogen, California, USA).
Macrophage polarization markers were detected as follows. After washing with PBS, centrifuged cells with anti-F4/80 and anti-CD86 or anti-CD206 (Invitrogen, California, USA) were incubated in the dark at 4 °C for 30 minutes. The cells were then washed once, suspended in PBS containing 1% FBS and analyzed by flow cytometry. Flow cytometry data were analyzed by FlowJo software v10.2 (BD, New Jersey, USA).
+ Open protocol
+ Expand
2

Tumor Cell Profiling by Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were stained with a panel of antibodies in PBS containing 2% FBS, 1% penicillin-streptomycin, and 1 mM EDTA. Tumor cells from primary tumor samples were identified by gating out leukocytes, endothelial, and stromal cells expressing human lineage markers: CD2 (RPA-2.10), CD3 (UCHT1), CD18 (6.7), CD31 (WM59), CD45 (HI30), and CD64 (10.1). Tumor cells from xenografts passaged in mice were identified by gating out stromal cells expressing mouse lineage markers: H-2Kd (SF1–1.1), H-2Kb (AF6–88.5) and muCD45 (30–F11). Anti-CD31 was obtained from eBioscience, and all other antibodies were obtained from BD Pharmingen. All lineage antibodies were biotinylated or directly conjugated to PE/Cy5. Labeled cells were then washed and stained with streptavidin-PE/Cy5 (BioLegend). DAPI was obtained from Invitrogen.
After gating out leukocytes, endothelial, stromal, and non-viable cells, the tumor cells were profiled for expression of TLR2. Anti-TLR2 (T2.5) was obtained from eBioscience. Cells were analyzed on a BD LSRFortessa. Events collected were analyzed using FlowJo Version 9.6.4 software (Tree Star).
+ Open protocol
+ Expand
3

Multimodal Immunolabeling of Diverse CNS Targets

Check if the same lab product or an alternative is used in the 5 most similar protocols
Catalogue numbers and concentrations of all antibodies are as follows. Anti-GFAP (130300, rat, 1:200), anti-occludin (711500, rabbit, 1:125) and anti-IgG (A11029, mouse, 1:100) were from Invitrogen. Anti–JAM-A (sc53623, mouse, 1:100) was from Santa Cruz Biotechnology. Fluoromyelin was from ThermoFisher (F34651, 1:300). Anti-fibrinogen (A0080, rabbit, 1:150) was from Dako. Anti-CD3 (16-0037-85, mouse, 1:100), anti-CD4 (14-9766-82, rat, 1:100), Anti-CD31 (550274, rat, 1:100), anti-CD45 (550539, rat, 1:100) were from eBioscience. anti-CD4 (ab183685, mouse, 1:50) was from Abcam. Anti-NeuN (MAB377, mouse, 1:100), anti-Olig2 (MABN50, mouse, 1:500) and anti-AQP4 (AB3594, rabbit, 1:200) were from Millipore. Anti-laminin (L9393, rabbit, 1:200) was from Sigma–Aldrich. Anti-Iba1 (109-19741, rabbit, 1:500) was from Wako.
+ Open protocol
+ Expand
4

Evaluation of Anti-Angiogenic Drug Effects

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sunitinib and sorafenib were from LC Laboratories (Woburn, MA, USA). Sodium bicarbonate and HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) were from Sigma-Aldrich. Recombinant human VEGF was from Peprotech (#100-20-10). Cycloheximide was purchased from Santa Cruz biotechnology (#SC-3508). For Western blot analysis, the following primary antibodies and concentrations were used: anti-phospho-Akt antibody (1:500) (#4060; Cell Signaling Technology), anti-Akt antibody (1:1000) (#2920; Cell Signaling Technology), anti-VEGFR-2 antibody (1:1000) (#2479; Cell Signaling Technology), anti-VEGFR-1 (1:500) (#sc-316; Santa Cruz biotechnology), anti-β-actin antibody (1:5000) (#A2228; Sigma Aldrich), anti-Tie-2 antibody (1:500) (#MAB313; R&D systems) and anti-FGFR-1 antibody (1:1000) (#sc-121; Santa Cruz Biotechnology). Immunohistochemical staining were performed with anti-CD31 antibody (#Rb-10333-PO; Thermo Scientific). For immunofluorescence anti-CD31 (1:50) (# 553370; BD Pharmigen) and anti-VEGFR-2 antibody (1:50) (#2479; Cell Signaling Technology) were used. For flow cytometry, the following antibodies and dilutions were used: anti-CD31 (1:100) (#17-0319; eBioscience), anti-avb3 integrin (1:100) (MAB1976; Millipore), anti-VCAM-1(1:100) (#12-1069; eBioscience), anti-ICAM-1 (1:100) (#12-0549; eBioscience) and anti-MCP-1 (1:100) (#12-7099; eBioscience).
+ Open protocol
+ Expand
5

Isolation of Lung Endothelial and Bone Marrow Monocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lungs were perfused with PBS and HBSS(+Collagenase 1 mg/ml; Sigma Aldrich, Switzerland) and minced before incubation with HBSS(+Collagenase) for 45 min and further processed for antibody incubation. Mouse lung cell suspension was incubated with anti-CD31(eBioscience, Austria, clone 390) antibody for 30 min in PBS (0.5% BSA) at 1 : 20 dilution in order to isolate lung ECs. To isolate monocytes from bone marrow cell suspension, the anti-CD115-biotin (eBioscience, clone AFS98) antibody was used at dilution of 1 : 50 in HBSS+2% FBS. Cell suspensions were incubated in primary antibody for 30 min at 4 °C followed by incubation with anti-rat IgG or streptavidin magnetic particles and sorted on LS columns according to the manufacturers recommendations (Miltenyi, Switzerland).
+ Open protocol
+ Expand
6

Mouse Blood Cell Immunophenotyping

Check if the same lab product or an alternative is used in the 5 most similar protocols
Whole mouse blood was collected into microcentrifuge tubes containing 100μl HEPES medium (132mM NaCl, 6mM KCl, 1mM MgSO4, 20mM HEPES, and 5mM glucose) as previously described2 . Samples were diluted 2× in HEPES medium, and then centrifuged at RT for 15 min at 100 × g. Platelet rich plasma was incubated for 15 min at RT in 100μl of HEPES medium containing the following antibodies: Anti-CD45.2, anti-CD31, anti-CD9, anti-GARP and anti-Ter119 (eBioscience) prior to flow cytometry analysis. Data were acquired using BD Fortessa flow cytometers and analysed using FlowJo (TreeStar).
+ Open protocol
+ Expand
7

Immunostaining of Cutaneous Squamous Cell Carcinoma

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tissue from freshly excised cSCC was obtained from patients during surgery at the Dermatology Department, University Hospital Southampton NHS Foundation Trust. The tissue samples (n=15 tumors) were snap frozen in liquid nitrogen, embedded in OCT medium, cryosectioned and immunostained as described previously (22 (link)). Primary antibodies included anti-CD3 (1:200, DAKO), anti-CD4 (1:50, Abcam), anti-CD8 (1:20, Invitrogen), anti-FOXP3 (1:20, eBioscience), anti-cytokeratin 16 (1:20, Thermo Scientific), anti-cytokeratin 17 (1:20, DAKO), anti CD31 (1:200, eBioscience), anti-CLA (1:200, Biolegend), anti-E-selectin (1:20, R & D Systems) and anti-OX40 (1:200, BD Biosciences). Fluorophore conjugated secondary antibodies comprised Alexa Fluor 488 goat anti-mouse IgG1a, Alexa Fluor 488 goat anti-rat IgM, Alexa Fluor 555 goat anti-rabbit IgG, Alexa Fluor 555 goat anti-rat IgG and Alexa Fluor 633 goat anti-mouse IgG2a (all from Invitrogen). Tissue sections were counterstained with DAPI (Sigma) before being mounted in Mowiol 4–88 (Harco) and imaged using a Zeiss Axioskop 2 fluorescence microscope or a Leica SP5 confocal microscope.
+ Open protocol
+ Expand
8

Phenotypic Characterization of Cultured Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
CPs were stained for surface antigen expression using combinations of the following antibodies to confirm typical phenotype at P5: anti-CD31 (eBioscience, UK), anti-CD34 (eBioscience), anti-CD44 (eBioscience, UK), anti-CD45 (Miltenyi Biotec), anti-CD90 (BD Biosciences, UK), anti-CD105 (Life Technologies), and anti-CD146 (Miltenyi Biotec). After staining, fluorescence was analyzed using a FACS Canto II flow cytometer and FACS Diva software (both BD Biosciences, UK).
+ Open protocol
+ Expand
9

Multi-antibody Panel for Cell Sorting

Check if the same lab product or an alternative is used in the 5 most similar protocols
Monoclonal, murine-specific antibodies from BioLegend included: anti-CD11c (N418), anti-CD11b (M1/70), anti-Gr-1 (RB6-8C5), anti-CD19 (6D5), anti-CD4 (RM4–5), anti-CD8α (53-6.7), anti-CD25 (PC61), anti-NK1.1 (PK136), anti-Thy1.2 (53-2.1), anti-CD45.2 (104), anti-EpCAM (G8.8), and anti-CD45 (30-F11). Antibodies from eBioscience included: anti-CD11b (M1/70), anti-CD4 (RM4–5), anti-CD8α (53-6.7), anti-Thy1.2 (53-2.1), anti-F4/80 (BM8), anti-CD49b (DX5), anti-CD5 (53-7.3), anti-CD45 (30-F11), anti-IRF4 (3E4), anti-GATA3 (TWAJ), anti-B220 (RA3-6B2), and anti-CD31 (390). Antibodies from BD Biosciences included: anti-CD11c (HL3), anti-CD25 (PC61), anti-Thy1.2 (53-2.1), anti-Ly6G (1A8), anti-α4β7 (DATK32), and anti-Siglec-F (E50-2440). An Alexa Fluor 488-conjugated anti-Siglec-F antibody was generated using purified anti-Siglec-F with an Alexa Fluor 488 monoclonal antibody labeling kit (Life Technologies).
Exclusion of DAPI (4',6-diamidine-2'-phenylindole dihydrochloride; Roche) or LiveDead (Life Technologies) identified live cells, which were enumerated with flow cytometric CountBright Absolute beads (Life Technologies), according to the manufacturer’s instructions. Sample data were acquired with a LSRII flow cytometer (BD Biosciences) and analyzed using FlowJo software (Tree Star, Inc.). Cells were sorted using a MoFlo XDP (Beckman Coulter) instrument.
+ Open protocol
+ Expand
10

Immunohistochemical Analysis of Solid Tumors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Solid tumors were fixed with 10% phosphate buffered formalin, processed, and embedded in paraffin.
The sections were dewaxed and stained with H&E under a light microscope at 10× magnification. Immunohistochemistry (IHC) was performed according to the manufacturer’s instructions (LSAB kit; Dako, Carpinteria, CA, USA). Images were taken using a microscope. Cryosections of tumors were stained with anti-CD31 (eBioscience) and anti-phospho-Stat 3 (Santa Cruz) antibodies, respectively, followed by a biotinylated secondary antibody and streptavidin-FITC with DAPI counterstaining to detect tumor vasculature. The fluorescence images were taken by a microscope (Nikon Eclipse ci, Tokyo, Japan), and processed by using Image pro-plus 6.0 software.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!